Navigation Links
Enrollment in Employer-Contracted Pharmacy Benefit 'Carve-Out' Increased by More than Six Million Lives
Date:4/6/2009

As Employers Continue Shift to Self-Insurance for Medical Benefits, Movement to Direct Contracting for Pharmacy Benefits Also Underway, According to Data from HealthLeaders-InterStudy

NASHVILLE, Tenn., April 6 /PRNewswire/ -- HealthLeaders-InterStudy, the leading provider of managed care market intelligence, reports that between January 2008 and July 2008 enrollment in pharmacy benefit plans for which employers contract directly with a pharmacy benefit manager (PBM), also known as a "carve-out," increased by more than six million lives to 55.9 million, a nearly 13 percent increase. Data to support this trend, and other enrollment information, can be found in the latest release of Managed Market Surveyor-Rx, a database product from HealthLeaders-InterStudy that delivers medical and pharmacy benefit enrollment by managed care organization and geography.

During the same period, HealthLeaders-InterStudy data reveals that self-insured medical enrollment grew by 1.6 million lives, or 2.2 percent, to more than 75.3 million members nationwide. By assuming more risk, employers can reduce the overall premium costs for each employee through the elimination of premium taxes, risk charges and other costs.

"Contracting directly with pharmacy benefit managers offers employers more options for benefit design and co-pay structure, enabling them to improve control of their drug benefit spending," said Lance Wolkenbrod, data analyst with HealthLeaders-InterStudy. "As companies continue to look for ways to better control costs, we'll likely see this trend continue as more employers move to direct contracting with pharmacy benefit managers."

Why Pharmaceutical Companies Need Managed Market Surveyor-Rx

Managed Market Surveyor-Rx delivers medical and pharmacy benefit enrollment data by managed care organization and geography (national, state, MSA) to better inform strategic planning and resource allocation. Relying on primary research and HealthLeaders-InterStudy's proprietary validation methodology, Managed Market Surveyor-Rx provides the most accurate managed care database available.

About HealthLeaders-InterStudy

HealthLeaders-InterStudy, a Decision Resources, Inc. company, is the authoritative source for managed care data, analysis and news. For more information, please visit www.HL-ISY.com.

About Decision Resources, Inc.

Decision Resources, Inc. is a cohesive portfolio of companies that offers best-in-class, high-value information and insights on important sectors of the healthcare industry. Clients rely on this analysis and data to make informed decisions. Please visit Decision Resources, Inc. at www.DecisionResourcesInc.com.

    For more information, contact:

    Lisa Osgood                                 Elizabeth Marshall
    HealthLeaders-InterStudy                    Decision Resources, Inc.
    781-296-2606                                781-296-2563
    losgood@hl-isy.com                          emarshall@dresources.com


       All company, brand, or product names contained in this document may be
         trademarks or registered trademarks of their respective holders.


'/>"/>
SOURCE HealthLeaders-InterStudy
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Governor Rendell Announces CHIP Enrollment Clinics at Several Rite Aid Stores
2. Watson Wyatt Identifies Major Benefit Trends During Open Enrollment Season
3. RESolutions Rapid Enrollment Solutions, LLC Mobilizes Team of Regional Recruitment Specialists(TM)
4. New Online Tool Makes Enrollment in Blue Cross of California Easier
5. Neurotech Announces Completion of Enrollment of its Phase II/III Retinitis Pigmentosa and Phase II Dry Age Related Macular Degeneration Clinical Studies
6. My Medicare Matters(TM) Advises Evaluating Your Current Medicare Part D Plan During Open Enrollment
7. Northwestern University and ACORN Commence National Enrollment for Metastatic Breast Cancer Study
8. Ceregene Completes Enrollment of Phase 2 Clinical Trial for Parkinsons Disease
9. 2008 Open Enrollment for Medicare Part D Prescription Drug Coverage and Medicare Advantage Plans Begins Today
10. Medicare Rx Beneficiaries Urged to Review Changes to Their Drug Plans and Compare with Other Plans During Open Enrollment
11. Patient Enrollment Completed in Phase IIb Trial of EpiCept(TM) NP-1 in Diabetic Peripheral Neuropathy
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/23/2017)... , ... February 23, 2017 , ... ... of Justice jointly issued a letter to withdraw previous guidance issued ... their gender identity. The guidance issued in May 2016 by the Obama Administration ...
(Date:2/23/2017)... , ... February 23, 2017 , ... ... with a clinician-based audience, will be participating in Rare Disease Day events, hosted ... D.C. In addition, Rare Disease Report, a website, weekly e-newsletter and quarterly publication, ...
(Date:2/23/2017)... , ... February 23, 2017 , ... Hamlin Dental Group ... that they are sponsoring a raffle. Throughout the month of February, patients who visit ... a gift card for a dinner for two at the Cheesecake Factory. , ...
(Date:2/23/2017)... Los Angeles, California (PRWEB) , ... February 23, ... ... for Global Sports Development will host a diverse symposium on “Doping ... School of Law and Sheppard Mullin Richter & Hampton LLP. The symposium will ...
(Date:2/23/2017)... ... 23, 2017 , ... ERT, a global data and technology ... Research, a leading clinical development service provider, has selected ERT’s Trial Oversight suite ... in part to an array of circumstances including the use of multiple data ...
Breaking Medicine News(10 mins):
(Date:2/23/2017)... 2017 Nevro Corp. (NYSE: NVRO), a global medical ... treatment of chronic pain, today reported financial results for the ... 2016 Accomplishment & Highlights: Achieved ... increase of 228% as reported, over the prior year ... of 612% over the prior year International ...
(Date:2/23/2017)... Calif. , Feb. 23, 2017 ... company focused on the development and commercialization of ... pain, announced that it will release fourth quarter ... Thursday, March 2nd, 2017. AcelRx management will host ... Time (1:30 p.m. Pacific Time) on March 2 ...
(Date:2/23/2017)... , Feb 23, 2017 ... Research and Markets has announced the ... Industry Forecast to 2025" report to their offering. ... of around 1.8% over the next decade to reach approximately $12.8 billion ... estimates and forecasts for all the given segments on global as well ...
Breaking Medicine Technology: